Differential regulation of soluble and membrane CD40L proteins in T cells

被引:38
|
作者
Matthies, Kelli M. G.
Newman, Jodie L.
Hodzic, Alma
Wingett, Denise G. [1 ]
机构
[1] Boise State Univ, Dept Biol, Boise, ID 83725 USA
[2] Univ Washington, Dept Med, Div Gerontol & Geriatr Med, Seattle, WA 98195 USA
[3] MSTMRI Res Inst, St Lukes Reg Med Ctr, Boise, ID 83712 USA
关键词
CD4 T cells; cell surface molecules; cellular activation; CD40L;
D O I
10.1016/j.cellimm.2006.08.001
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
CD40 ligand is an important immunoregulatory protein expressed by T cells. This protein exists as two isoforms, a membrane glycoprotein and a truncated soluble form. Here we demonstrate that membrane and soluble CD40L (sCD40L) are differentially regulated depending upon the activation stimulus. In T cell receptor activated cells, both membrane and sCD40L proteins are expressed and CD28 costimulation further increases their expression. The dissection of TCR generated signals into calcium and PKC-dependent pathways demonstrates that calcium is sufficient to induce membrane CD40L yet insufficient for sCD40L. In contrast, sCD40L is preferentially induced by PKC. Moreover, sCD40L production is blocked by Zn2+-dependent metalloproteinase inhibitors while membrane CD40L is concurrently increased. This profile suggests the potential involvement of the ADAM-10 protease which was subsequently shown to cleave membrane CD40L to generate sCD40L. Given the role of sCD40L in numerous disease pathologies and its ability to activate proximal and distal immune responses, the regulated cleavage of CD40L may likely contribute to disease mechanisms. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:47 / 58
页数:12
相关论文
共 50 条
  • [1] Differential downstream effects of CD40 ligation mediated by membrane or soluble CD40L and agonistic Ab: A study on purified human B cells
    Cognasse, F
    Chavarin, P
    Acquart, S
    Sabido, O
    Beniguel, L
    Genin, C
    Richard, Y
    Garraud, O
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2005, 18 (01): : 65 - 74
  • [2] The role of soluble CD40L in immunosuppression
    Schlom, Jeffrey
    Jochems, Caroline
    Gulley, James L.
    Huang, Jianping
    ONCOIMMUNOLOGY, 2013, 2 (01):
  • [3] Characterization and application of two novel monoclonal antibodies against CD40L: epitope and functional studies on cell membrane CD40L and studies on the origin of soluble serum CD40L
    Fan, Y
    Ge, Y
    Zhu, H
    Wang, Y
    Yang, B
    Zhuang, Y
    Ma, H
    Zhang, X
    TISSUE ANTIGENS, 2004, 64 (03): : 257 - 263
  • [4] CD40L expression in plasma of volunteers following LPS administration: A comparison between assay of CD40L on platelet microvesicles and soluble CD40L
    Mobarrez, Fariborz
    Sjovik, Carolina
    Soop, Anne
    Hallstrom, Lars
    Frostell, Claes
    Pisetsky, David S.
    Wallen, Hakan
    PLATELETS, 2015, 26 (05) : 486 - 490
  • [5] Soluble CD40L in systemic lupus erythematosus
    Alexandrova, EN
    Novikov, AA
    Popkova, TV
    Novikova, DS
    Klukvina, NG
    Nasonov, EL
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 134 - 134
  • [6] Platelet and soluble CD40L in meningococcal sepsis
    Inwald, David P.
    Faust, Saul N.
    Lister, Paula
    Peters, Mark J.
    Levin, Michael
    Heyderman, Robert
    Klein, Nigel J.
    INTENSIVE CARE MEDICINE, 2006, 32 (09) : 1432 - 1437
  • [7] Soluble CD40L and cardiovascular risk in women
    Schönbeck, U
    Varo, N
    Libby, P
    Buring, J
    Ridker, PM
    CIRCULATION, 2001, 104 (19) : 2266 - 2268
  • [8] Platelet and soluble CD40L in meningococcal sepsis
    David P. Inwald
    Saul N. Faust
    Paula Lister
    Mark J. Peters
    Michael Levin
    Robert Heyderman
    Nigel J. Klein
    Intensive Care Medicine, 2006, 32 : 1432 - 1437
  • [9] Evaluation of soluble CD40L measurements.
    Varo, N
    Nuzzo, R
    Libby, P
    Schönbeck, U
    CLINICAL CHEMISTRY, 2004, 50 (06) : A112 - A112
  • [10] Editing of the CD40L Gene Restores Regulated CD40L Expression in X-HIGM Patient T Cells
    Hubbard, Nick
    Song, Yumei
    Hagin, David
    Sommer, Karen
    Scharenberg, Andrew
    Torgerson, Troy
    Rawlings, David
    MOLECULAR THERAPY, 2015, 23 : S191 - S192